Oxybutynin ER
Sponsors
Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Christopher Patrick Smith, Cairo University
Conditions
CognitionMemoryOveractive BladderVasomotor Symptoms
Phase 3
OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER
NCT01050114
Start: 2013-08-31End: 2018-07-31Target: 36Updated: 2016-08-30
Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms
NCT05637671
Start: 2022-02-10End: 2023-12-31Target: 146Updated: 2023-02-08